<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "https://rcpp-ie.com/nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">143</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:892805cc-c5d0-571f-8841-3ba335035073</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Review of Clinical Pharmacology and Pharmacokinetics – International Edition</journal-title>
        <abbrev-journal-title xml:lang="en">RCPP</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-6583</issn>
      <issn pub-type="epub">2945-1922</issn>
      <publisher>
        <publisher-name>PHARMAKON-Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.61873/VUQT8301</article-id>
      <article-id pub-id-type="publisher-id">34721</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Isotretinoin and psychiatric adverse effects: A literature review</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Lotsaris</surname>
            <given-names>Kleomenis</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Grech</surname>
            <given-names>Vasiliki Sofia</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Grech</surname>
            <given-names>Ioanna</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Kefala</surname>
            <given-names>Vasiliki K.</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0003-2222-8535</uri>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Rallis</surname>
            <given-names>Efstathios</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Medical Doctor, Resident Psychiatrist in Psychiatry Department of General Hospital of Athens “Evaggelismos”, Athens, Greece</addr-line>
        <institution>Medical Doctor, Resident Psychiatrist in Psychiatry Department of General Hospital of Athens “Evaggelismos”</institution>
        <addr-line content-type="city">Athens</addr-line>
        <country>Greece</country>
      </aff>
      <aff id="A2">
        <label>2</label>
        <addr-line content-type="verbatim">Medical Doctor, Department of Care and Social Services, Healthcare Services, University of West Attica, Athens, Greece</addr-line>
        <institution>Medical Doctor, Department of Care and Social Services, Healthcare Services, University of West Attica</institution>
        <addr-line content-type="city">Athens</addr-line>
        <country>Greece</country>
      </aff>
      <aff id="A3">
        <label>3</label>
        <addr-line content-type="verbatim">Department of Biomedical Sciences. School of Health and Care Sciences, University of West Attica, Campus 1, Athens, Greece</addr-line>
        <institution>Department of Biomedical Sciences. School of Health and Care Sciences, University of West Attica, Campus 1</institution>
        <addr-line content-type="city">Athens</addr-line>
        <country>Greece</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Academic editor: </p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2024</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>02</month>
        <year>2024</year>
      </pub-date>
      <volume>38</volume>
      <issue>s1</issue>
      <fpage>23</fpage>
      <lpage>29</lpage>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/C215B297-0910-5965-95F6-AD31E103D42B">C215B297-0910-5965-95F6-AD31E103D42B</uri>
      <permissions>
        <copyright-statement>Kleomenis Lotsaris, Vasiliki Sofia Grech, Ioanna Grech, Vasiliki K. Kefala, Efstathios Rallis</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>Abstract</label>
        <p>This literature review article discusses the use of isotretinoin and examines its association with psychiatric adverse effects, particularly depression and suicidal ideation. The article presents historical and molecular data on isotretinoin and delves into the literature regarding its psychiatric side effects in the treatment of acne vulgaris. It tries to answer in questions about whether the scientific community has overlooked the significance of the underlying disease and explores the awareness of healthcare professionals regarding these potential adverse effects. Additionally, it investigates the likelihood of these effects based on the available literature to date.</p>
      </abstract>
    </article-meta>
  </front>
</article>
